This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SanDiego-based biopharmaceuticals developer Receptos has set the initial, estimated pricing range for its IPO, saying in a filing Thursday that it now expects its IPO pricing to be between $14.00 and $16.00
SanDiego-based medical device manufacturer Tandem Diabetes Care priced its IPO last night, saying it will offer up 8,000,000 shares of its common stock at $15.00 The company--which develops an insulin pump--will start trading today on the NASDAQ Global Market as TNDM.
SanDiego-based ServiceNow , the developer of software-as-a-service for enterprise IT management, is expected to price its IPO Thursday, as the first, technology-focused IPO since the Facebook debacle. The firm, which has set initial pricing range of its IPO at between $15.00 and $17.00 READ MORE>>.
SanDiego-based Otonomy , which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. otonomy biopharmaceuticals biotech lifescience merger acquisition inner disease exit otic pricing' and $16.00 Otonomy filed for its IPO on July 14th. READ MORE>>.
SanDiego-based precision medicine developer Ignyta has priced its IPO, saying last night that it is offering up 5,245,000 shares of its common stock at $9.15 The IPO will raised $48.0M for the company. Ignyta will trade on the NASDAQ Capital Market as RXDX, starting today.
SanDiego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 Ambit priced well below its estimated initial public offering range, which had been set at between $13.00 The company will start trading today on the NASDAQ Global Market as AMBI. and $15.00
SanDiego-based Seismic , a developer of sales and marketing software, has raised $100M more in a funding round, which values the company at $1 billion, the company said on Tuesday. Rowe Price, plus General Atlantic, JMI Equity, and Jackson Square Ventures. The funding round came from Lightspeed Venture Partners, T.
SanDiego-based Peregrine Semiconductor , the developer of CMOS, RF integrated circuits, has set an estimated pricing range for its its IPO. According to a filing by the firm this morning, it is estimating a IPO price of between $14.00 and $16.00 The firm is offering 5,500,000 shares of its stock in its IPO.
SanDiego-based Trius Therapeutics , which is looking to IPO on the Nasdaq as TSRX, indicated in a filing today that it is looking to price its IPO at between $12.00 Trius is focused on discovery, development, and commercialization of antibiotics. and $14.00
SanDiego-based Trius Therapautics has slashed its IPO offering price, saying today in a filing with the SEC that it will offer 10,000,000 shares of its common stock at $5.00 The firm, which will list on the Nasdaq Global Market as TSRX, had initially said it would sell 6,000,000 shares of its stock at between $12.00 and $14.00
SanDiego-based Zogenix has updated its S-1, saying this morning the firm intends to offer 6 million shares of its common stock on the Nasdaq Global Market as ZGNX. The firm also said it currently estimates the firm's initial offering price at between $12.00 and $14.00 Zogenix had filed for an IPO in September.
SanDiego-based Evofem Biosciences, which is developing biopharmaceuticals for women's contraception and related areas, says it has priced a $50M, public offering, and also will receive up to an additoinal $50M upon exercise of accompanying short-term warrant.
SanDiego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 per share, raising just over $1 billion for the company. The company will begin trading this morning on the Nasdaq Global Select Market as TSP.
The Alliance estimates that Southern California’s tech community could be one-third the size of Silicon Valley’s by supporting or further developing the six pillars it already has for innovation to occur.
On-demand, taxi app developer Flywheel , which has been in an intense battle with Uber, Lyft, Sidecar and others in the LA market, said this week that it will offer $5, flat rate rides on its service in Los Angeles and SanDiego until April 6th. diego ride smartphone taxi uber transportation mobile flywheel' READ MORE>>.
SanDiego-based Anametrix , which develops marketing analytics software, said Monday that it has tied its software to Tableau , the developer of visual data analytics tools. Price of the new product was not announced. Anametrix is led by Pelin Thorogood. READ MORE>>.
SanDiego-based Deposit Defender says it has launched a new app, which helps renters photo-document rental property inspections, in order to prevent future loss of their security deposits. Pricing on the app was not announced. Are you a renter, tired of landlords always claiming damages and never returning your security deposit?
SanDiego-based NextWave Wireless , a developer of wireless technology, reported Wednesday afternoon that it is being delisted from the NASDAQ stock market, as of July 23rd. per share closing bid price requirement of the exchange.
SanDiego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 and $16.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB.
SanDiego-based biopharmaceuticals developer Receptos is trading flat after its initial public offering, after pricing last night at $14.00 The developer of biopharmaceuticals for treating immune and metabolic diseases priced at the low end of its estimated IPO range, which was $14.00 READ MORE>>.
SanDiego-based security software developer Websense announced this morning that it has signed a definitive agreement to be acquired by private equity firm Vista Equity Partners. Websense said the deal is an approximate premium of 29 percent over the firm''s Friday closing price. per share in cash for the company.
Grab yours today before prices go up. Each half-day Xcelerating Life Sciences forum is dedicated to helping industry leaders develop meaningful partnerships and explore bold new ideas to overcome healthcare’s biggest challenges. Can’t make the SanDiego. Early bird tickets are on sale now for only $99.
SanDiego-bsaed Fate Therapeutics , which is developing biopharmaceuticals base don adult stem cells to treat a number of orphan diseases, is up slightly in trading after its initial public offering this morning. Fate Therapeutics priced at $6.00 in afternoon trading, up around 14.33% over its opening price.
BigMachines , a developer of cloud-based software for product configuration, pricing, quoting, and proposals, has scored funding from SanDiego private quity investor JMI Equity. Financial details of the new funding were not disclosed.
SanDiego-based security software developer Websense reported Wednesday that it has launched a new, mobile security product aimed at mobile devices such as iPads, iPhones, and Android. Pricing on the new product was not announced. READ MORE>>.
SanDiego-based VMIX , the developer of online video management and hosting services, reported today that it has launched a new product aimed at helping its customers rent videos on the Facebook social networking site. Pricing on the new offering was not announced. READ MORE>>.
SanDiego-based Covario , a developer of search engine marketing and search engine optimization software, said today that it has launched a new product focused on creating mobile web sites. Pricing on the new offering was not disclosed. READ MORE>>.
SanDiego-based Sightly , which develops video advertising technology, said Thurday that it has launched a new platform aimed at delivering personalized, video ads from local businesses to prospective customers. Pricing on the new product was not disclosed. READ MORE>>.
SanDiego-based biopharmaceuticals developer Viking Therapeutics has set the estimated pricing for its IPO, saying in a filing Tuesday that it expects to price its IPO at between $10.00 The company is developing treatments for treating Type 2 diabetes and other metabolic diseases. and $12.00 in its offering.
SanDiego-based Websense , the developer of cyber security tools, said today that it has debuted a new, cloud-based cybersecurity product called ACE in the Cloud. Pricing on the new product was not announced. READ MORE>>.
SanDiego-based Memjet , a developer of color printing technology, said this week that it has added Mark W. Legg also served at American Reprographics Company, Vivitar, and Price Waterhouse. Legg as the firm's new Chief Financial Officer. Legg joins from Genearl Atomics, where he was SVp and CFO.
Reports this morning say that SanDiego-based ServiceNow is planning to start its IPO roadshow this week, as the firm looks to brave a post-Facebook-IPO market. According to reports , the firm expects to price its IPO as late June.
SanDiego-based biopharmaceuticals firm Otonomy was up today in early trading, after pricing 6.25 The company priced at the high end of its initial estimated IPO range, which was $14.00 The company priced at the high end of its initial estimated IPO range, which was $14.00 per share last night. READ MORE>>.
SanDiego-based Trius Therapeutics is set to hit the markets today, after pricing its IPO last night. Trius, a biopharmaceuticals firm developing antibiotics, priced its IPO and increased the number of shares it would sell last night, dropping the offering price to $5.00
SanDiego-based Regulus Therapeutics has adjusted its anticipated IPO terms, saying in a filing this morning that it now anticipates its initial public offering price of its stock to be $4.00 Regulus is a developer of microDNA-based biopharmaceuticals. The firm had initially been targeted at offering 4.5M and $12.00
Publicly held biopharmaceuticals firm MediciNova , which is based in SanDiego, said last night that it has raised $20M in funding in a deal with Aspire Capital Fund, LLC. Medicinova said that Aspire will purchase the $20M in common stock at market prices.
Los Angeles-based online advertising technology developer Rubicon Project set the pricing range for its initial public offering Thursday, saying that it hopes to offer 6,770,995 shares of its common stock at between $15.00 and $17.00 The company said it has been approved to list on the New York Stock Exchange as RUBI.
He did note that in the four markets where the company has gone live since launching its business in January 2019 — SanDiego, Los Angeles, the Inland Empire , and Sacramento — has yielded an annualized revenue run rate of over $400 million in gross merchandise value (the total value of home sales transacted on its platform).
SanDiego-based Novatel Wireless announced a new wireless module this morning, aimed at the remote asset monitoring market. Pricing of the new module was not disclosed. Novatel's new SA-G+ device runs on CDMA2000 1X networks. Novatel is best known for its MiFi mobile hotspot products. READ MORE>>.
SanDiego-based fleet driver safety product developer Lytx announced Friday that it has launched a new product specifically for the trucking industry. Pricing on the new product was not announced.
SanDiego-based ShowUhow , a developer of an online web site focused on video instruction guides for manufacturers and retailers, said today that it has raised $3M in a funding round. The firm said the Series A funding came from Syncom Venture Partners.
Frank Slootman , the CEO of SanDiego-based ServiceNow , headed up the software developer''s very successful IPO last year. Rowe Price, Fidelity, Tiger Global, and Sutter Hill, Greylock, Redpoint, and Index Ventures. That funding came from T. READ MORE>>.
SanDiego-based green energy technology developer Nuvve , which is developing vehicle-to-grid load balancing technology, says it has started participating in California's wholesale energy markets, via an effort with the University of California SanDiego.
SanDiego-based video-based, driver safety products developer Lytx says it is rolling out a new product specifically aimed at mid-sized, commercial fleets. Pricing on the new product was not announced. READ MORE>>. lytx drivecam insurance video safety driver management fleet vehicle monitoring'
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content